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Structure-based design of peptide presentation on a viral
surface: the crystal structure of a plant/animal virus chimera 
at 2.8 Å resolution
Tianwei Lin1, Claudine Porta2, George Lomonossoff2 and John E Johnson1
Background: We employed a genetically engineered icosahedral plant virus,
cowpea mosaic virus (CPMV), as an expression and presentation system to
display a 14 amino acid linear antigenic epitope found in a capsid protein of
human rhinovirus 14 (HRV14). 
Results: Gram quantities of the CPMV/HRV14 chimera were made in plants and
purified particles were crystallized in a form isomorphous with wild-type CPMV.
The 2.8 Å resolution structure of the chimera shows that the inserted loop is well
ordered and that if the loop were intact, a phenylalanine residue of CPMV would
be placed in a hydrophilic environment. The resultant strain may make the loop
an attractive substrate for endogenous plant proteases, as roughly 80% of the
inserted polypeptides are cleaved, allowing the phenylalanine to be partially
buried. Altering the phenylalanine to an arginine could relieve the stress,
reducing the propensity for cleavage and increasing the likelihood that the
peptide will assume a structure closely similar to its structure in HRV14. 
Conclusions: Successful crystallization of other CPMV chimeras in forms
isomorphous with the native virus suggests that this is a viable system for
structure-based design of peptide presentation. 
Introduction
Synthetic polypeptides of roughly 10–40 amino acids have
a broad spectrum of uses ranging from antigens for
epitope-based vaccines to specific inhibitors of cell surface
interactions. The efficacy of such peptides is generally
increased by attaching them to a carrier protein in order to
extend their lifetime in the cellular milieu and to present
them in a manner in which they will be better recognized
by the biological target, be it a B cell or a specific cell-
surface binding protein. A common way to attach a
polypeptide to a protein is through a reactive group on the
synthetic peptide which may then form a covalent bond
with a cysteine residue of the carrier protein [1]. An alter-
native method, that has been popular more recently, is to
genetically insert an appropriate oligonucleotide into a
protein-encoding gene and then express the altered gene
in a heterologous expression system resulting in the
protein carrying the polypeptide [2]. Seminal work of this
type was done with the hepatitis B core protein which
spontaneously assembles into an icosahedral particle when
expressed in Escherichia coli [3]. As the structure of this
protein is unknown, the genetic constructs were made by
adding the appropriate oligonucleotides to the 5′ and 3′
ends of the hepatitis B core protein gene. The resultant
polypeptides added to the N and C termini did not, fortu-
itously, interfere with assembly and were displayed as
linear peptides on the surface with a biological efficacy
exceeding that of the peptides chemically attached to
other protein carriers. 
The first structure-based inserts of this type were made
with poliovirus, where the availability of the 2.8 Å X-ray
structure [4] suggested that inserts made in an exposed
loop near the particle fivefold axes (B-C loop of VP1, see
below) would be accessible on the surface of the particle. In
contrast to the hepatitis B core protein system, an infec-
tious clone of the virus [5] was used and the genetically
inserted polypeptide was amplified with the virus as it mul-
tiplied in the host [6]. Although some of the inserts reduced
or inhibited virus replication, many of the constructs multi-
plied at nearly normal levels, providing candidates for live-
virus, peptide-based vaccines [7]. A danger with an RNA
animal virus based system of this type is that mutations
may occur that increase virulence of the chimera. This pos-
sibility was demonstrated when the loop used for inser-
tional mutagenesis in a carrier type 1 (P1/Mahoney)
poliovirus was exchanged with the amino acid sequence of
the same loop (six residues) in type 2 (P2/Lansing)
poliovirus and the resultant virus not only displayed the
mosaic of antigenic sites from both viruses as expected, but
also the mouse adaptation and neurovirulence of the
P2/Lansing poliovirus [8]. The only previous report of a
chimeric virus structure was this poliovirus P1/P2 hybrid [9]
where B-C loops of the VP1 subunits of the two
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poliovirus strains were exchanged. The two viruses con-
tributing to the chimera were closely related and relatively
small conformational alterations were found in the
exchanged loop when it was placed in the different context. 
During the past three years, we have demonstrated that
cowpea mosaic virus (CPMV) is an excellent ‘expression
system’ for polypeptides [2,10,11]. CPMV is an icosahe-
dral RNA comovirus with a capsid structure closely similar
to poliovirus [12]. Each of the loops between -strands in
the poliovirus subunits have comparable loops in CPMV
subunits and the so-called B-C loop of VP1 used in
poliovirus is highly exposed in CPMV as well. Primary and
tertiary structures of three different comoviruses show that
the native polypeptide sequences and conformations in
this loop are highly variable (T Lin et al., unpublished
data), suggesting that different amino acid sequences
could be accommodated in this region without inhibiting
normal virus function. Employing an infectious clone
developed for mutational studies of CPMV, a natural and
a synthetic, site-directed, restriction site were used to
insert polypeptides within the B-C loop [10]. CPMV
replication is remarkably tolerant of alterations to this loop
and multiplies at, or near, wild-type levels (∼2 g per kilo-
gram of leaves in blackeye beans) with a wide variety of
polypeptides inserted. We have, however, had mixed
results in the use of this system for the production of neu-
tralizing peptide-based antibodies. 
Antibodies generated in mice by injection with CPMV car-
rying a polypeptide from the gp41 protein of HIV inhibit
syncytia formation in an HIV neutralization assay at a level
comparable with the best protein or peptide-based anti-
bodies found to date [13].  In contrast, antibodies raised
against a CPMV chimera virus containing the NIm-IA
epitope from human rhinovirus 14 (HRV14) do not neu-
tralize the animal virus [11]. As the structure of HRV14 is
known at 2.8 Å resolution [14], the conformation of this
linear epitope is known with high precision. To establish
the role of conformation in generating effective peptide
antibodies, we have crystallized both the CPMV/HRV14
and the CPMV/HIVgp41 chimeras. We report here the
2.8 Å structure of the CPMV/HRV14 chimera and provide
a detailed comparison of the polypeptide conformation in
the native and CPMV context. Substantial conformational
differences exist in the polypeptide conformation in its
native and heterologous environment and this probably
explains the lack of observed neutralizing activity when
HRV14 is grown in the presence of antibodies raised
against this chimera. The structure provides a possible
explanation for the differences in the polypeptide confor-
mation in the native and heterologous surroundings and
suggests that a single mutation to a contextual CPMV
residue may produce closely similar conformations in the
different environments. Because of the packing of the
CPMV particles in a cubic unit cell, genetic alterations,
which occur near the pentamer axes, do not affect the
crystal contacts, thus both chimeras crystallized are iso-
morphous with the native virus. If this is generally true
and the majority of the chimera crystallizations are not
affected by the inserts, CPMV provides an ideal system for
the rational design of peptide presentations. 
Results
Generation of the chimeric virus
The molecular biological strategies employed for generat-
ing the CPMV/polypeptide chimeras as well as the struc-
ture-based rationale are summarized in Figure 1. The
sequence KDATGIDNHREAKL corresponds to the
NIm-IA site of HRV14 [15] and is located in the B-C
loop on the VP1 subunit. The chimeric virus, termed
CPMV/HRV14, grew normally in plants and produced
yields similar to wild-type virus. The constructs were
genetically stable with no evidence of reversion to the
wild-type primary structure after 10 generations of serial
inoculation. The CPMV/HRV14 S protein, corresponding
to VP1 of poliovirus and carrying the inserted HRV14
polypeptide in the chimera, reacted with a polyclonal
serum raised against HRV14 particles, and serum raised in
rabbits against CPMV/HRV14 could bind to denatured
HRV14 VP1 in western blots [10]. Because the structure
of the NIm-IA site on the native HRV14 particle is known
[14], CPMV/HRV14 is an ideal candidate for investigating
the effect of a heterologous protein environment on the
structure of an epitope. 
Prior to crystallization, particles of CPMV/HRV14 were
analyzed by SDS-PAGE. In addition to the bands corre-
sponding to the unmodified large (L) coat protein (analo-
gous to an uncleaved version of VP2 and VP3 in
picornaviruses) and the modified S protein containing the
HRV14 sequence, a lower molecular weight band was also
seen. N-terminal sequence analysis showed that this
protein arises as a result of spontaneous cleavage between
the C-terminal two residues of the insert in the S protein
(Fig. 1). A similar cleavage has been noted previously with
a CPMV chimera expressing an epitope from HIV type 1
[13] and appears to be a feature of all chimeras in which the
polypeptide is inserted between residues Ala22 and Pro23
of CPMV (C Porta, unpublished data). The large fragment
of the cleaved form of the S protein, called S′, consists of
the last residue inserted into CPMV and the C-terminal
192 residues of the S protein. Up to 80% of the S protein of
a virus preparation can be cleaved (data not shown). The
N-terminal residues of the native S protein, which are
detached from S during the cleavage of the chimera, are
involved in the interface with fivefold related S proteins in
the CPMV particle and it is unlikely that assembly could
occur with S′, the cleaved version of the subunit observed
in the gel. Thus, cleavage probably occurs post-assembly.
If assembly occurs after the cleavage, the independent
polypeptide (CPMV1–22 + 1085–1097) must still be associ-
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ated with S′, through non-covalent interactions, in a nearly
native configuration to induce assembly. In either case, as
the particles were assembled, we anticipated that the small
polypeptide cleaved from the S protein (carrying all but
one residue of the insert) would still be associated with the
particle and presumably visible in the electron density map
of the chimera. 
Structure determination
Large crystals of the CPMV/HRV14 chimera were grown
under conditions nearly identical to those used to crystal-
lize the wild-type virus [16] and X-ray diffraction patterns
with measurable reflections beyond 1.9 Å were observed.
The native and chimeric crystals are isomorphous, with
I23 space group symmetry and a = 317 Å. The particle
position and orientation are defined by the crystal lattice
and only the particle fivefold axis is non-crystallographic.
Interparticle contacts occur along threefold lattice and par-
ticle axes. The fivefold particle axes are fully exposed to
solvent with adequate interparticle space in the crystal to
accommodate the genetically inserted polypeptide, consis-
tent with the formation of isomorphous crystals for native
and chimera viruses. The conformation of the inserted
loop does not appear to be affected by crystal contacts. 
An averaged difference electron density map with coeffi-
cients (|Fnative|–|Fchimera|)ei(native) employed in the Fourier
series is expected to show positive density for residues in
the native structure that changed position due to the
inserted polypeptide and negative density for regions
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Figure 1
Generation of the CPMV chimera. (a)
Residues in the B-C loops of CPMV and
the location of restriction sites, as well as the
residues in the chimera and the position of the
spontaneous cleavage in the chimera. (b) The
location of the exposed loop of the chimera on
the particle surface with the insertion
represented in red. There are two unique
restriction enzyme sites, NheI (natural) and
AatII (prepared by site-directed mutagenesis),
in the region encoding the B-C loop of the
small subunit in the infectious clone. These
two sites were used in the cassette
mutagenesis. Oligonucleotides were
introduced to restore the native sequence of
those residues removed that participate in
secondary structure hydrogen bonds (CPMV
residues 16–19) and to insert the NIm-IA
antigenic sequence of HRV14 between Ala22
and Pro23. Two residues, Asp1091 and
Glu1095 (numbering from HRV14), that were
important for the NIm-IA immunogenicity are
drawn as larger circles. The chimera thus
generated has the foreign sequence
presented at the pentamers of the virus
capsid (lower right). The majority of the virus
isolated was fragmented between Lys1097
and Leu1098.
CPMV/WT
ßB-PPAPFSDV-ßC
CPMV/HRV14
ßB-PPA-NIM IA-PFSDV-ßC
NheI
AatII
ßB ßC
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23
ßB ßC
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23
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1095
1097
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occupied by residues in the chimera that were not occu-
pied in the native structure. All significant positive and
negative density in this map was found in the immediate
vicinity of the B-C loop of the S subunit where the
foreign sequence had been inserted (Fig. 2, Table 1). This
demonstrates that the insertion created only local changes
in the capsid structure. Because of the native phase bias in
the averaged difference electron density map computed
with amplitudes (|Fchimera|–|Fnative|)ei(native), it was not
possible to define the positions of the inserted residues or
the altered positions of CPMV residues directly. A real
space averaging procedure [17] was applied to refine
phases for the chimera amplitudes. The mainchain of the
modified B-C loop was clearly defined in the electron
density map computed with amplitudes Fchimeraei(real space
averaging) and sidechains of 12 of the 14 inserted residues
were unambiguously modeled (Fig. 3). 
Structure analysis
The first 13 inserted residues formed an extended chain
on the particle surface and they are held in place by a
hydrogen bond that creates a pseudo-closed loop configu-
ration (Table 1). The outermost radius of the insert is
167 Å compared to the maximum radial extension of 159 Å
in the native particle, which occurs in the loop where the
insert is made. The electron density for the inserted
residues and for CPMV residues in the immediate vicinity
of the insert was somewhat weaker when compared with
density for residues not close to the modification. This
suggested conformational flexibility at the insert that may
be static (slightly different, but rigid, conformations in the
60 averaged subunits) or dynamic (a flexibility corre-
sponding to continuous mobility of that portion of the
polypeptide in the crystal). Despite the apparent mobility,
the density was well above the background and unam-
biguous for model building. Residues immediately follow-
ing the cleavage site, which included the last residue of
the insert and five residues of the native CPMV sequence,
were clearly defined in the electron density, but residues
24–28 of CPMV were in altered positions and conforma-
tions when compared to the native CPMV structure
(Table 1, Fig. 4). 
Only two residues within the inserted loop of the chimera
formed hydrogen bonds with other residues and no intra-
loop interactions were formed (Table 2a). The cleavage
released the penultimate residue of the insertion, increas-
ing the mobility of the loop and allowing it to adopt a con-
formation unconstrained by a short distance between the
two ends of the loop. Without the hydrogen bond
between Arg1094 and Ser25, it seems likely that the
inserted loop would be significantly more mobile. In con-
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Figure 2
An averaged, difference electron density map,
with coefficients (|Fnative|–|Fchimera|)ei(native)
employed in the Fourier series. (a) A
stereoview of the electron density for the
entire icosahedral asymmetric unit showing
that the only significant differences between
the native and chimera structures are at the
B-C loop (top of figure). (b) A close view of
the strong density observed for residues in
the native structure (shown as the refined
model) that changed position due to the
inserted polypeptide. In the native structure,
Phe24 is in a hydrophobic environment
between residues in the loop connecting B
and C strands and the loop connecting the
H and I strands. 
trast to the environment in HRV14, where the distance
between the residues at the beginning and the end of the
loop is roughly 9 Å, the comparable separation in the
chimera was about 19 Å. 
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Table 1
CPMV residues with altered positions in the chimera. 
CPMV CPMV/HRV14
Interacting Interacts Interaction Distance Interacts Interaction Distance
group with type (Å) with type (Å)
O Pro20 NH1 Hydrogen 2.7 NH2 Hydrogen 2.6
NH2 bond Arg155 bond
Arg155
O Pro21 N Hydrogen 3.2 NH2 Hydrogen 3.3
Phe24 bond Arg155 bond
O Ala22 None NE Hydrogen 2.6
Arg155 bond
Pro23 None None
O Phe24 NH1 Hydrogen 2.5 None
Arg155 bond
Ser25 None None
Asp26 None None
Val27 None None
N Thr28 O Hydrogen 3.2 O Hydrogen 3.5
Ala151 bond Ala151 bond
Figure 3
Electron density for the chimera particle. The
mainchain of the modified B-C loop was
clearly defined in the averaged electron
density map computed with amplitudes
Fchimeraei(real space averaging) and sidechains of
12 of the 14 inserted residues were
unambiguously modeled. The model is shown
below and fit to the density above. The 
-strands and sidechains that comprise the
immediate environment of Phe24 are also
shown in gray.
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Figure 4
A ribbon diagram of the icosahedral
asymmetric unit of the chimera. The inserted
loop of the chimera is in red. The loop in
yellow shows the original position of the native
B-C loop of CPMV. The icosahedral
asymmetric unit of CPMV is occupied by two
gene products, the large (L) subunit
composed of a single polypeptide chain with
two -barrel domains (shown in different
shades of green) and the small (S) subunit
composed of one -barrel domain (shown in
blue). The structure of the L subunit was not
affected by the changes made in the S
subunit (see Fig. 2a). The CPMV structure is
organized like the picornavirus capsids with L
corresponding to VP2 (dark green) and VP3
(blue-green) and S corresponding to VP1.
The ribbon diagrams were generated by the
program RIBBONS [18].
Table 2
Interactions within the inserted NIm-IA loop (1085–1098).
Atoms involved Distance Interaction Within 
(Å) type B-C loop
(a) CPMV/HRV14 chimera
OD1 Asp1086–NH2 Arg1094 3.7 Salt bridge Yes
N Arg1094–O Ser25 3.1 Hydrogen bond No
(b) Native HRV14 structure
NZ Lys1085–O Ala1096 3.2 Hydrogen bond Yes
O Als1087–N Ile1090 2.7 Hydrogen bond Yes
O Asn1092–N Glu1095 2.8 Hydrogen bond Yes
O Asn1092–N Ala1096 2.9 Hydrogen bond Yes
OD1 Asn1092–N Glu1095 3.1 Hydrogen bond Yes
ND2 Asn1092–OE2 Glu1095 3.4 Hydrogen bond Yes
O His1093–N Ala1096 2.9 Hydrogen bond Yes
O His1093–N Lys1097 3.2 Hydrogen bond Yes
O His1093–N Leu1098 2.8 Hydrogen bond Yes
O Arg1094–N Lys1097 3.2 Hydrogen bond Yes
NH1 Arg1094–OD1 Asp1101 3.1 Salt bridge No
NH2 Arg1094–OD1 Asp1101 3.3 Salt bridge No
NH2 Arg1094–OD2 Asp1101 3.2 Salt bridge No
Table 1 lists the CPMV residues that moved due to the
insertion. Analysis of the chimera indicated that if the
insert remained intact, Phe24 would be entirely exposed
to solvent, suggesting that the cleavage susceptibility of
the chimera may be encouraged by conformational strain
induced by the exposed hydrophobic residue. In the
native structure, Phe24 is buried between hydrophobic
residues in the B-C and H-I loops (Fig. 2) and it is
obvious, with hindsight, that it must be displaced from
this location when residues are inserted adjacent to it.
Phe24 occupies a partially hydrophobic environment in
the cleaved chimera (Fig. 3). Although there are signifi-
cant differences in the conformational details of the
insertion in its present form, when compared with the
same sequence in its native context (Fig. 5), the site is
placed at a highly exposed position of the particle (as
shown in Fig. 6), explaining the peptide-like antigenicity
discussed below. 
Discussion
The native structure of NIm-IA was dominated by intra-
loop hydrogen bonds (Table 2b, Fig. 5) which are respon-
sible for three sharp turns in the epitope [14]. The hydro-
gen bonds and the consequent circuitous path of the
native chain must result from the constraint of the short
distance (9 Å) between residues at the beginning and the
end of the loop in the native HRV14 particle because the
loop is entirely exposed to solvent and there are no
obvious interactions with residues outside of the loop.
The terminal residues of the loop in HRV14 are held in
close proximity by a hydrogen bond (NZ Lys1085 and O
Ala1096) and secondary structure interactions with H
and I strands. As all of the conformationally important
interactions are intra-loop, the same residues inserted in
CPMV, with the two ends of the loop held in close prox-
imity, should result in conformational fidelity between the
native HRV14 epitope and the epitope implanted on
CPMV. Modeling studies suggest that a Phe24→Arg
alteration will not only place an appropriate residue in a
hydrophilic environment at this position, but may also set
up a network of hydrogen bonds with Asp44 and Asp26
that will hold the two ends of the loop in close proximity.
This construct is currently being prepared for crystallo-
graphic and immunogenic studies. 
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Figure 5
A stereoview comparing the chimera loop 
(in red) with the native NIm-IA loop of HRV14
(in gray); Asp1091 and Glu1095 define the
NIm-IA epitope, in that changes to either of
these residues stop the virus from being
neutralized by specific monoclonal antibodies,
and are labeled in both loops. The NIm-IA
loop displayed three turns, with the two ends
of the loop 9 Å apart; the chimera loop was
relatively smooth and 19 Å separate the two
ends. The ribbons in this figure were forced to
pass through the C positions in both
structures.
Figure 6
A stereoview of the space-filling drawing of
CPMV particles carrying the inserted
residues. The large subunit is shown in blue-
green (VP3-like domain) and green (VP2-like
domain). The small subunit is shown in blue
and the inserted residues are in red. All atoms
are shown as spheres of 1.8 Å. The maximum
radial extent of the inserted (red) loop is
167 Å from the particle center, compared to a
maximum radial extent of 158 Å found in the
native structure. The space-filling drawing was
made with the program MidasPlus [19,20].
Conclusions
The results presented here are the first example of the
determination of the structure of an antigenic epitope from
an animal virus presented on the surface of a plant virus.
The ability to observe the structure of an inserted epitope
has significant practical consequences. It will be possible
to correlate the binding and immunogenic properties of
polypeptide inserts in CPMV with their three-dimensional
presentation and thus enable the rational refinement of
their display leading to the production of chimeras that are
optimal for their anticipated biological function. 
Materials and methods
Preparation and propagation of the CPMV/HRV14 chimera 
The molecular biological details of the chimera preparation and propa-
gation have been previously reported [11].
Crystallization and data collection
The CPMV/HRV14 chimera was purified with the same preparation
used for native particles [21]. The virus was stored in 0.1 M potassium
phosphate, pH 7.0 and 1 mM EDTA at a concentration of 35 mg ml–1.
The crystals were grown at room temperature by sitting drop vapor dif-
fusion method with 0.25 M ammonium sulfate and 2% polyethylene
glycol 8000 as the reservoir solution [22]. The drop was made by
mixing equal amounts of the virus solution and the reservoir solution.
102 diffraction patterns from seven crystals were collected at 4°C on
the F1 station at the Cornell High Energy Synchrotron Source. The
oscillation angle for each pattern was 0.3°. Measurable diffraction
maxima up to 1.9 Å were observed. 
Data reduction
Diffraction patterns were readily indexed [23,24] and processed [25] in
space group I23 and they were determined to be isomorphous with the
native virus crystals with a = 317.0 Å. The diffraction data were post-
refined [26] and a data set was obtained containing 114 978 reflections
with a minimum Bragg spacing of 2.8 Å and an Rmerg = 5.6% for all the
data with I/(I)≥4. Table 3 lists the percentage of theoretically possible
data measured in different resolution shells and the correlation coeffi-
cients in the last cycle of the phase refinement by real space averaging. 
Difference Fourier and phase refinement
The CPMV/HRV14 data were scaled to the native CPMV data ([12];
T Lin et al., unpublished data) by dividing the data into 30 resolution
shells and applying a scale factor for each shell. The difference Fourier
synthesis and the other procedures were performed with the CCP4
suite [27] of crystallographic programs. The real space averaging
package RAVE [17] was used to refine phases for the chimera ampli-
tudes. Initial masks for the averaging were generated with the program
MAMA [17] employing the native CPMV atomic model. Two temporary
masks were first generated from atoms in a single icosahedral asym-
metric unit which is referred to as the reference asymmetric unit. The
first mask was generated from all atoms of the CPMV atomic model
with an atomic radius of 3 Å. The second mask was generated with arti-
ficially large atomic radii of 5–10 Å for native atoms of B-C loop where
the insertions were made. These two masks were combined by the
logical operator ‘OR’ of the MAMA program to generate an initial mask.
Attempts were made to modify the initial mask to include only the
volume for the reference asymmetric unit using the ‘TRIM’ command in
the program MAMA, but the editing procedure was not entirely suc-
cessful as shown by excessive reduction in the mask of the icosahedral
asymmetric unit. The following strategy was then developed to eliminate
regions of overlap between the mask as assigned to neighboring parti-
cles and to the particle with the reference asymmetric unit. The differ-
ence approach for mask generation described worked very well. The
initial mask was generated as described above. Then another mask was
generated from atoms in non-crystallographically and crystallographi-
cally related asymmetric units in the immediate vicinity of the reference
asymmetric unit, but not including the reference asymmetric unit. This
second mask was subtracted from the initial mask, defining the mask for
the reference asymmetric unit used for averaging by the logical operator
‘BUTNOT’ of the MAMA program. This operation eliminated the inclu-
sion of the neighboring atoms in the mask, as judged by the visual
inspection. The mask was further edited in the program O [28] to adjust
the volume around the insertion site to better accommodate the extra
density anticipated in the chimera without overlapping masks assigned
to neighboring particles. Significant improvements on averaging were
observed by the application of the edited masks. The converged corre-
lation coefficient was 0.93 after six averaging cycles for data between
25.0 and 2.8 Å. One round of simulated annealing [29] was carried out,
with a current R = 25% for data between 12.0 and 2.8 Å.
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